Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.

B32B3 is a cell-permeable, ATP-competitive inhibitor of VprBP that blocks phosphorylation of histone 2A at Thr120 in DU-145 human prostate cancer cells (IC50 = 500 nM).1 It exhibits over 100-fold selectivity for VprBP against a panel of 33 other protein kinases.1 B32B3 strongly suppresses the proliferation of DU-145 cells, which overexpress VprBP, but not MCL normal human prostate cells, which have low levels of VprBP expression.1 At 5 mg/kg twice a week over three weeks, B32B3 inhibits the growth of DU-145 xenograft tumors in mice by 70-75%.1
WARNING This product is not for human or veterinary use.
1. VprBP has intrinsic kinase activity targeting histone H2A and represses gene transcription. Mol. Cell 52(3), 459-467 (2013).